二酰甘油激酶在信号转导中的作用。
Diacylglycerol Kinases in Signal Transduction.
机构信息
Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), University of Piemonte Orientale, 28100 Novara, Italy.
出版信息
Int J Mol Sci. 2022 Jul 29;23(15):8423. doi: 10.3390/ijms23158423.
Abstract
In recent years, the significant research efforts put into the clarification of the PI3K/AKT/mTOR pathway resulted in the approval of the first targeted therapies based on lipid kinase inhibitors [...].
摘要
近年来，在阐明 PI3K/AKT/mTOR 通路方面所做的大量研究工作促成了第一批基于脂质激酶抑制剂的靶向治疗药物的批准[...]。
相似文献
1
Diacylglycerol Kinases in Signal Transduction.二酰甘油激酶在信号转导中的作用。
Int J Mol Sci. 2022 Jul 29;23(15):8423. doi: 10.3390/ijms23158423.
2
Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.二酰甘油激酶α通过与Src的功能性相互作用促进三维癌细胞生长并限制药物敏感性。
Oncotarget. 2014 Oct 30;5(20):9710-26. doi: 10.18632/oncotarget.2344.
3
Inhibition of PI3K/Akt/mTOR signaling by natural products.天然产物对PI3K/Akt/mTOR信号通路的抑制作用
Anticancer Agents Med Chem. 2013 Sep;13(7):967-70. doi: 10.2174/1871520611313070001.
4
Achieving cancer cell death with PI3K/mTOR-targeted therapies.利用 PI3K/mTOR 靶向治疗实现癌细胞死亡。
Ann N Y Acad Sci. 2013 Mar;1280(1):15-8. doi: 10.1111/nyas.12028.
5
Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.PI3K/AKT/mTOR 信号通路在卵巢癌中的作用：生物学和治疗意义。
Semin Cancer Biol. 2019 Dec;59:147-160. doi: 10.1016/j.semcancer.2019.05.012. Epub 2019 May 22.
6
Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors.抑制点的选择：PI3K/AKT/mTOR 通路抑制剂的比较综述。
Mol Cancer Ther. 2014 May;13(5):1021-31. doi: 10.1158/1535-7163.MCT-13-0639. Epub 2014 Apr 18.
7
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.PI3K/Akt/mTOR 抑制剂在癌症中的应用：从实验室到临床。
Semin Cancer Biol. 2019 Dec;59:125-132. doi: 10.1016/j.semcancer.2019.07.009. Epub 2019 Jul 16.
8
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review.联合 TKI 抑制 PI3K/Akt/mTOR 通路克服 CML 中的 TKI 耐药：综述。
Med Oncol. 2021 Jan 16;38(1):10. doi: 10.1007/s12032-021-01462-5.
9
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis.PI3K/AKT/mTOR 通路抑制剂单药治疗卵巢癌的疗效：一项荟萃分析。
Gynecol Oncol. 2021 Nov;163(2):433-444. doi: 10.1016/j.ygyno.2021.07.008. Epub 2021 Jul 10.
10
Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).二酰基甘油激酶 δ 通过富含亮氨酸重复的 PH 结构域蛋白磷酸酶 2（PHLPP2）调节 Akt 的磷酸化。
J Biol Chem. 2013 Jan 18;288(3):1439-47. doi: 10.1074/jbc.M112.407379. Epub 2012 Nov 26.
引用本文的文献
1
Photoaging: UV radiation-induced cGAS-STING signaling promotes the aging process in skin by remodeling the immune network.光老化：紫外线辐射诱导的cGAS-STING信号通路通过重塑免疫网络促进皮肤衰老进程。
Biogerontology. 2025 Jun 20;26(4):123. doi: 10.1007/s10522-025-10268-1.
2
Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases.二酰甘油激酶及其在脂质代谢和相关疾病中的作用。
Int J Mol Sci. 2024 Dec 9;25(23):13207. doi: 10.3390/ijms252313207.
3
Elucidating CTLA-4's role in tumor immunity: a comprehensive overview of targeted antibody therapies and clinical developments.阐明细胞毒性T淋巴细胞相关抗原4（CTLA-4）在肿瘤免疫中的作用：靶向抗体疗法及临床进展综述
Mol Divers. 2024 Jul 10. doi: 10.1007/s11030-024-10917-6.
4
Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.西利珠单抗治疗儿童慢性活动性 EBV 感染和 EBV 相关噬血细胞性淋巴组织细胞增生症。
Orphanet J Rare Dis. 2023 Sep 22;18(1):297. doi: 10.1186/s13023-023-02861-9.
本文引用的文献
1
AAV-delivered diacylglycerol kinase DGKk achieves long-term rescue of fragile X syndrome mouse model.腺相关病毒（AAV）递送的二酰基甘油激酶 DGKk 可实现脆性 X 综合征小鼠模型的长期挽救。
EMBO Mol Med. 2022 May 9;14(5):e14649. doi: 10.15252/emmm.202114649. Epub 2022 Apr 4.
2
Pediatric Atypical Hemolytic Uremic Syndrome Advances.儿科非典型溶血尿毒综合征的研究进展。
Cells. 2021 Dec 18;10(12):3580. doi: 10.3390/cells10123580.
3
Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review).PI3K 抑制剂的研发：临床试验进展及新策略（综述）。
Pharmacol Res. 2021 Nov;173:105900. doi: 10.1016/j.phrs.2021.105900. Epub 2021 Sep 20.
4
Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.X 连锁淋巴组织增生症 1 型中的二酰基甘油激酶 α。
Int J Mol Sci. 2021 May 29;22(11):5816. doi: 10.3390/ijms22115816.
5
Precise Regulation of the Basal PKCγ Activity by DGKγ Is Crucial for Motor Coordination.DGKγ 通过精确调控基础 PKCγ 活性对于运动协调至关重要。
Int J Mol Sci. 2020 Oct 23;21(21):7866. doi: 10.3390/ijms21217866.
6
Beyond Lipid Signaling: Pleiotropic Effects of Diacylglycerol Kinases in Cellular Signaling.超越脂质信号：二酰基甘油激酶在细胞信号中的多效性作用。
Int J Mol Sci. 2020 Sep 18;21(18):6861. doi: 10.3390/ijms21186861.
7
New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.二酰基甘油激酶、磷酸脂酸和磷酸脂酸结合蛋白的新纪元。
Int J Mol Sci. 2020 Sep 16;21(18):6794. doi: 10.3390/ijms21186794.
8
Subcellular Localization Relevance and Cancer-Associated Mechanisms of Diacylglycerol Kinases.二酰基甘油激酶的亚细胞定位相关性和与癌症相关的机制。
Int J Mol Sci. 2020 Jul 26;21(15):5297. doi: 10.3390/ijms21155297.
9
Potential role of diacylglycerol kinases in immune-mediated diseases.二酰基甘油激酶在免疫介导性疾病中的潜在作用。
Clin Sci (Lond). 2020 Jul 17;134(13):1637-1658. doi: 10.1042/CS20200389.
10
Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An Update.二酰基甘油激酶作为多种疾病的新兴潜在药物靶点：最新进展。
Front Cell Dev Biol. 2016 Aug 17;4:82. doi: 10.3389/fcell.2016.00082. eCollection 2016.
Zotero 插件